25 August 2023, 6:39 pm 1 minute
Reuters exclusively reported that Novo Nordisk has employed Thermo Fisher as its second contract producer for its massively common weight-loss drug Wegovy. Novo Chief Monetary Officer Karsten Munk Knudsen informed Reuters in Might the corporate had signed up a second contract producer in america, however the identification of the corporate has not beforehand been reported. This was adopted by one other unique that Catalent’s plant in Bloomington, Indiana, will fill injection pens for Novo Nordisk’s Wegovy as a part of the 2 firms’ expanded provide settlement. Catalent’s shares briefly jumped on the information.
Shares in Thermo jumped as a lot as 4% throughout New York buying and selling on Wednesday.
Subjects of Curiosity: Well being
Kind: Reuters Greatest
Sectors: Prescribed drugs & Healthcare
Nations: United States
Win Sorts: Exclusivity
Story Sorts: Unique / Scoop
Media Sorts: Textual content
Buyer Affect: Vital Nationwide Story